Skip to Content


Having trouble identifying your medications? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Featured Tool

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Featured Tool

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Featured Tool

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in Medical

Gene Test May Predict Success of Cancer Drug in Certain Patients

The first genetic "marker" -- or signal -- to predict response to the cancer drug Keytruda (pembrolizumab) has been identified by researchers. The marker -- mismatch repair (MMR) deficiency -- predicted responses to the drug in patients with several different types of cancer, the study authors said. Among patients with colon cancer, 62 percent of...

Posted today in Medical

Immune-Based Drug Shows Promise Against Advanced Lung Cancer

A new drug appears to harness a person's immune system to fight the most common form of lung cancer, according to new clinical trial findings. The drug, nivolumab, reduced patients' risk of death from non-small cell lung cancer by 27 percent compared with patients who received docetaxel, a commonly used chemotherapy medication, researchers said. The...

Posted 2 days ago in New Drug Approvals

FDA Approves Xifaxan (rifaximin) for the Treatment of IBS-D (Irritable Bowel Syndrome with Diarrhea)

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that its wholly owned subsidiary, Salix Pharmaceuticals, Inc., has received approval from the U.S. Food and Drug Administration (FDA) for Xifaxan 550 mg for the treatment of IBS-D in adults. The FDA approval of Xifaxan 550 mg is based on data from three phase 3 studies, TARGET...

Posted yesterday in New Drug Approvals

FDA Approves Rapamune (sirolimus) for Rare Lung Disease Lymphangioleiomyomatosis

The U.S. Food and Drug Administration today approved Rapamune (sirolimus), to treat lymphangioleiomyomatosis (LAM), a rare, progressive lung disease that primarily affects women of childbearing age. This is the first drug approved to treat the disease. LAM is characterized by an abnormal growth of smooth muscle cells that invade lung tissues, including...

Posted 3 days ago in Clinical Trials

Pivotal Study Results Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma

Amgen (NASDAQ: AMGN) today announced the publication of primary results from the Phase 3 OPTiM study in the Journal of Clinical Oncology (JCO). The data published in JCO, which were previously presented at the Annual Meetings of the American Society of Clinical Oncology (ASCO) in 2013 and 2014, demonstrated a significantly higher durable response rate...

Posted today in Medical

Millennials Turning Their Backs on Religion

Millennials -- those born in the 1980s and 1990s -- are the least religious generation of Americans in the last six decades, a new study says. For the study, researchers analyzed data from 11.2 million participants in four national surveys of U.S. teens, aged 13 to 18, conducted between 1966 and 2014. The investigators found that millennials are less...

Posted today in Medical

Vets With PTSD Might Need Sleep Apnea Screening: Study

For U.S. veterans with post-traumatic stress disorder (PTSD), the risk of sleep apnea increases along with the severity of the mental health condition, a new study contends. Sleep apnea -- a common sleep disorder in which breathing frequently stops and starts -- is potentially serious. Researchers looked at 195 Iraq and Afghanistan veterans who visited...

Posted today in Medical

150 People May Have Had Contact With Lassa Fever Victim: CDC

At least 150 people may have had contact with a New Jersey man who died Monday in that state of Lassa fever, but most of them aren't at serious risk of infection, U.S. health officials reported Thursday. The unidentified 55-year-old man had returned to the United States on May 17 after traveling to Liberia in West Africa. Lassa fever is a viral disease...

Posted today in Medical

FDA Warns of Complications From Facial Fillers

Soft tissue fillers used in cosmetic procedures can accidentally be injected into blood vessels in the face and cause serious harm, the U.S. Food and Drug Administration warns. The fillers are approved to treat wrinkles or to enhance cheeks or lips. Injection of facial fillers into blood vessels can cause blockages that restrict blood supply to tissues....

Posted today in Medical

Babies Prefer Sound of Other Babies Over Adults

Babies would rather listen to other babies than adults, and this preference may help in their language development, a new study suggests. This finding might help explain why many adults seem to instinctively choose to use "baby-talk" with infants, according to one of the study's authors. "Perhaps, when we use a high, infant-like voice pitch to speak...

Read more news...

Recently added consumer and prescribing information: Viberzi, Stiolto Respimat, Kybella, Corlanor, Cresemba, Zarxio, Farydak, Lenvima, Ibrance, Glyxambi

Posted in Blog

Harnessing the Power of the Poliovirus as a Cancer Cure

Polio, a highly infectious and crippling disease, was certainly one of the most feared viruses in the 20th century. Each year, thousands of children were left paralyzed. Polio has been successfully eliminated in the U.S. for decades due to a widespread vaccine program. So why would a group of researchers be interested in injecting the […]

Posted in Blog

Biosimilars in 2015: What Can We Expect?

On Friday, March 6th, 2015 the FDA approved Sandoz’s Zarxio, the first official biosimilar that will be made available in the U.S. Zarxio, a recombinant granulocyte colony-stimulating factor used to boost white blood cells after cancer treatments, is the long-awaited biosimilar for filgrastim (Amgen’s Neupogen). The FDA noted in their briefs that Zarxio was “highly […]

Posted in Blog Adds Mayo Clinic Disease Reference is pleased to announce it has licensed select content from Mayo Clinic to provide more timely and trustworthy medical condition and disease information. The articles include detailed information about medical diseases such as allergies, back pain, depression, erectile dysfunction, and type 2 diabetes. Each article includes informative sections which may include an overview, symptoms, when […]

See more blog posts or follow us on twitter.